Shares of Humana Inc. HUM rallied 1.65% to $295.04 Friday, on what proved to be an all-around favorable trading session for ...

Barclays raised the firm’s price target on Humana (HUM) to $322 from $270 and keeps an Equal Weight rating on the shares. The firm revised up ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

This was the stock's fourth consecutive day of gains.

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers ...

The decision to raise Medicare Advantage plan payments by over $25 billion has led to a positive response in the stock market.

The U.S. health insurance industry, referred to as Health Maintenance Organization (HMO), is aided by membership growth on ...

With large opportunities in its target markets, management aims to continue growing at a fast pace with a long-term annual earnings per share growth goal of 11%-15%. While Humana appears focused ...

AM Best, a global credit rating agency, maintained its Long-Term Issue Credit Rating of "bbb" (Good) for Humana Inc .’s $1.25 billion 5.375% senior unsecured notes due in 2031. The rating affirmation ...